Skip to main content

Dicyclomine Oral Presentations

Last Updated: October 21, 2022
Status: Current

Products Affected - Description
    • Dicyclomine hydrochloride capsule, Hikma, 10 mg, bottle, 100 count, NDC 00143-3126-01
    • Dicyclomine hydrochloride capsule, Hikma, 10 mg, bottle, 1000 count, NDC 00143-3126-10
    • Dicyclomine hydrochloride solution, Hikma, 10 mg/5 mL, 473 mL bottle, NDC 00054-0622-63
    • Dicyclomine hydrochloride tablet, Hikma, 20 mg, bottle, 100 count, NDC 00143-1227-01
    • Dicyclomine hydrochloride tablet, Hikma, 20 mg, bottle, 1000 count, NDC 00143-1227-10
    • Dicyclomine hydrochloride capsule, Mylan (Viatris), 10 mg, bottle, 100 count, NDC 00378-1610-01 - discontinued
    • Dicyclomine hydrochloride capsule, Mylan (Viatris), 10 mg, bottle, 500 count, NDC 00378-1610-05 - discontinued
    • Dicyclomine hydrochloride tablet, Mylan (Viatris), 20 mg, bottle, 100 count, NDC 00378-1620-01 - discontinued
    • Dicyclomine hydrochloride tablet, Mylan (Viatris), 20 mg, bottle, 500 count, NDC 00378-1620-05 - discontinued
    • Dicyclomine hydrochloride capsule, Teva, 10 mg, bottle, 100 count, NDC 00591-0794-01
    • Dicyclomine hydrochloride capsule, Teva, 10 mg, bottle, 1000 count, NDC 00591-0794-10
    • Dicyclomine hydrochloride tablet, Teva, 20 mg, bottle, 100 count, NDC 00591-0795-01
    • Dicyclomine hydrochloride tablet, Teva, 20 mg, bottle, 1000 count, NDC 00591-0795-10
Reason for the Shortage
    • Hikma did not provide a reason for the shortage.
    • Lannett has dicyclomine capsules and tablets available.
    • Mylan discontinued the 20 mg tablets in June 2021. The 10 mg tablet presentations were discontinued in 2022.
    • Par Pharmaceuticals has dicyclomine oral solution available.
    • Teva did not provide a reason for the shortage.
Available Products
    • Dicyclomine hydrochloride capsule, Lannett, 10 mg, bottle, 100 count, NDC 00527-0586-01
    • Dicyclomine hydrochloride capsule, Lannett, 10 mg, bottle, 1000 count, NDC 00527-0586-10
    • Dicyclomine hydrochloride tablet, Lannett, 20 mg, bottle, 100 count, NDC 00527-1282-01
    • Dicyclomine hydrochloride tablet, Lannett, 20 mg, bottle, 1000 count, NDC 00527-1282-10
    • Dicyclomine hydrochloride solution, Par Pharmaceuticals, 10 mg/5 mL, 473 mL bottle, NDC 00603-1161-58

Estimated Resupply Dates

    • Hikma has all dicyclomine oral presentations on allocation.
    • Teva has dicyclomine 10 mg capsules in 100-count and 20 mg tablets in 1,000-count bottles on back order, and the company estimates release dates of early-November 2022. The 20 mg tablets in 100-count bottles are on back order, and the company estimates a release date of late-October. The 10 mg capsules in 1,000-count bottles are on back order, and the company estimates a release date of mid-December 2022.

Updated

Updated October 21, 2022 by Anthony Trovato, PharmD, BCPS. Created January 22, 2019 by Stephen Andrews, PharmD, BCPS, CPPS, Drug Information Specialist. © 2022, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer